| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |